Skip to main content
Caplight Logo









Veravas

Veravas

Private
Austin, TexasHealthcare & Life Scienceshttps://veravas.com/

Last Round

Accelerator

Jun 5, 2025

Total Funding Raised

$4M

Company Overview

Veravas is a biotechnology company that provides a platform to manage sample preparation and diagnostic solutions for early disease detection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

clinical diagnosticsAlzheimer's testingblood-based diagnosticsliquid biopsylaboratory-developed testLDTbiomarker enrichmentmagnetic bead technologyneurodegenerative disease screeningresearch-use-onlyRUOtauopathy diagnosticsbiotech equipmentprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Veravas Comparables

Compare Veravas with similar companies based on industry and business-model similarity.

Veravas comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ALZpath, Inc.
77%
NeuroDex
76%
C₂N Diagnostics
76%

Veravas Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 5, 2025
Convertible DebtFeb 19, 2020

Key People

Founding team and executive leadership

Joshua Soldo

Chief Scientific Officer & Co-Founder

Founding Team

Nancy Carson

Chief Operating Officer

Executive Team

Veravas Investors

Notable investors and investment history

Veravas investors
InvestorRounds
MedTech InnovatorAccelerator
American Heart Association VenturesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 287% MoM.

  • Jan 21, 2026

    Monthly visitors increased 53% MoM.

Veravas Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Veravas Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Veravas's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range14
Year Founded2017
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?